First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial
Marion Thibaudin(Inserm), François Ghiringhelli(Inserm)
Cited by 104
Related Papers
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
|Journal of Clinical Investigation|2010|985
CD4<b>+</b>CD25<b>+</b> regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner
|The Journal of Experimental Medicine|2005|918
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
|Annals of Oncology|2015|284